These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19786649)

  • 1. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice.
    Suzuki H; Ohkuchi A; Matsubara S; Takei Y; Murakami M; Shibuya M; Suzuki M; Sato Y
    Hypertension; 2009 Nov; 54(5):1129-35. PubMed ID: 19786649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
    Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
    Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice.
    Lu F; Longo M; Tamayo E; Maner W; Al-Hendy A; Anderson GD; Hankins GD; Saade GR
    Am J Obstet Gynecol; 2007 Apr; 196(4):396.e1-7; discussion 396.e7. PubMed ID: 17403433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
    Xiang QQ; Yang Z; Huai J; Wang GJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats.
    Murphy SR; LaMarca BB; Cockrell K; Granger JP
    Hypertension; 2010 Feb; 55(2):394-8. PubMed ID: 20026766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates.
    Makris A; Yeung KR; Lim SM; Sunderland N; Heffernan S; Thompson JF; Iliopoulos J; Killingsworth MC; Yong J; Xu B; Ogle RF; Thadhani R; Karumanchi SA; Hennessy A
    Hypertension; 2016 Jun; 67(6):1263-72. PubMed ID: 27091894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.
    Szalai G; Xu Y; Romero R; Chaiworapongsa T; Xu Z; Chiang PJ; Ahn H; Sundell B; Plazyo O; Jiang Y; Olive M; Wang B; Jacques SM; Qureshi F; Tarca AL; Erez O; Dong Z; Papp Z; Hassan SS; Hernandez-Andrade E; Than NG
    PLoS One; 2014; 9(11):e110867. PubMed ID: 25393290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional excretion of angiogenic factors in women with severe preeclampsia.
    Buhimschi CS; Magloire L; Funai E; Norwitz ER; Kuczynski E; Martin R; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Obstet Gynecol; 2006 May; 107(5):1103-13. PubMed ID: 16648417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia.
    Li Z; Zhang Y; Ying Ma J; Kapoun AM; Shao Q; Kerr I; Lam A; O'Young G; Sannajust F; Stathis P; Schreiner G; Karumanchi SA; Protter AA; Pollitt NS
    Hypertension; 2007 Oct; 50(4):686-92. PubMed ID: 17724276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia.
    Ohkuchi A; Hirashima C; Suzuki H; Takahashi K; Yoshida M; Matsubara S; Suzuki M
    Hypertens Res; 2010 May; 33(5):422-7. PubMed ID: 20150910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
    Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
    Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia.
    Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Arai F; Watanabe T; Kario K; Suzuki M
    Hypertens Res; 2007 Feb; 30(2):151-9. PubMed ID: 17460385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus.
    Qazi U; Lam C; Karumanchi SA; Petri M
    J Rheumatol; 2008 Apr; 35(4):631-4. PubMed ID: 18278839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers.
    Tsao PN; Wei SC; Su YN; Chou HC; Chen CY; Hsieh WS
    Pediatrics; 2005 Aug; 116(2):468-72. PubMed ID: 16061605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.